- Home
- BSM vs LIVN Comparison
BSM vs LIVN Comparison
Compare BSM & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSM | LIVN |
|---|---|---|
| Founded | 1876 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BSM | LIVN |
|---|---|---|
| Price | $14.23 | $79.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $14.00 | ★ $72.43 |
| AVG Volume (30 Days) | 284.6K | ★ 698.1K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.40% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | ★ $469,919,000.00 | N/A |
| Revenue This Year | $11.03 | $9.79 |
| Revenue Next Year | $9.63 | $6.63 |
| P/E Ratio | ★ $12.82 | $198.60 |
| Revenue Growth | ★ 8.35 | N/A |
| 52 Week Low | $11.90 | $41.02 |
| 52 Week High | $15.49 | $85.27 |
Technical Indicators
Market Signals| Indicator | BSM | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 48.87 |
| Support Level | $13.21 | $61.63 |
| Resistance Level | $14.25 | $80.96 |
| Average True Range (ATR) | 0.33 | 2.28 |
| MACD | 0.04 | -0.70 |
| Stochastic Oscillator | 61.65 | 19.72 |
Price Performance
Historical ComparisonAbout BSM Black Stone Minerals L.P.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests. The company owns mineral interests in approximately 16.9 million gross acres.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.